Država: Združene države Amerike
Jezik: angleščina
Source: NLM (National Library of Medicine)
GLYCOPYRROLATE (UNII: V92SO9WP2I) (GLYCOPYRRONIUM - UNII:A14FB57V1D)
Medical Purchasing Solutions, LLC
INTRAMUSCULAR
PRESCRIPTION DRUG
In Anesthesia: Glycopyrrolate Injection is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the volume and free acidity of gastric secretions; and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation. When indicated, Glycopyrrolate Injection may be used intraoperatively to counteract surgically or drug - induced or vagal reflexes associated arrhythmias. Glycopyrrolate protects against the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarizing muscle relaxants. In Peptic Ulcer: For use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated. Known hypersensitivity to glycopyrrolate or any of its inactive ingredients. In addition, in the management of
Glycopyrrolate (glycopyrrolate) Injection, 0.2 mg/mL, is available as: 0.2 mg/1 mL Single-dose Vials packaged in 25s (NDC 70069- 011 -25) 0.4 mg/2 mL (0.2 mg/mL) Single-dose Vials packaged in 25s (NDC 70069- 012 -25) 1 mg/5 mL (0.2 mg/mL) Multiple-dose Vials packaged in 25s (NDC 70069- 013 -25) 4 mg/20 mL (0.2 mg/mL) Multiple-dose Vials packaged in 25s (NDC 70069- 014 -10) Store at 20 C to 25 C (68 F to 77 F) [See USP Controlled Room Temperature]. To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For Product Inquiry call 1-800-417-9175. Manufactured By: Wintac Limited Bangalore-562 123 India Code No.: KR/DRUGS/KTK/28/289/97 Manufactured for: Somerset Therapeutics, LLC Mendham, NJ 07945 ST- GLY/P/01 Issued: January 2017
Abbreviated New Drug Application
GLYCOPYRROLATE- GLYCOPYRROLATE INJECTION MEDICAL PURCHASING SOLUTIONS, LLC ---------- GLYCOPYRROLATE INJECTION, USP RX ONLY NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL DESCRIPTION Glycopyrrolate Injection is a synthetic anticholinergic agent. Each 1 mL contains: Glycopyrrolate, USP 0.2 mg Water for Injection, USP q.s. Benzyl Alcohol, NF 0.9 % (preservative) pH adjusted, when necessary, with hydrochloric acid and/or sodium hydroxide. For Intramuscular (IM) or Intravenous (IV) administration. Glycopyrrolate is a quaternary ammonium salt with the following chemical name: 3[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl pyrrolidinium bromide. The molecular formula is C H BrNO and the molecular weight is 398.33. Its structural formula is as follows: 19 28 3 Glycopyrrolate occurs as a white, odorless crystalline powder. It is soluble in water and alcohol, and practically insoluble in chloroform and ether. Unlike atropine, glycopyrrolate is completely ionized at physiological pH values. Glycopyrrolate Injection is a clear, colorless, sterile liquid; pH 2.0 – 3.0. The partition coefficient of glycopyrrolate in a n-octanol /water system is 0.304 (log P= -1.52) at ambient room temperature (24 C). CLINICAL PHARMACOLOGY Glycopyrrolate, like other anticholinergic (antimuscarinic) agents, inhibits the action of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These peripheral cholinergic receptors are present in the autonomic effector cells of smooth muscle, cardiac muscle, the sinoatrial node, the atrioventricular node, exocrine glands and, to a limited degree, in the autonomic ganglia. Thus, it diminishes the volume and free acidity of gastric secretions and controls excessive pharyngeal, tracheal, and bronchial secretions. Glycopyrrolate antagonizes muscarinic symptoms (e.g., bronchorrhea, bronchospasm, bradycardia, and intestinal hypermotility) induced by cholinergic drugs such as the anticholinesterase Preberite celoten dokument